Equity Using Interventions for Pain and Depression (EQUIPD)
公平使用疼痛和抑郁干预措施 (EQUIPD)
基本信息
- 批准号:10595133
- 负责人:
- 金额:$ 155.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdministratorAnxietyAppointmentCaringClinicClinic VisitsClinical TrialsConsultationsControl GroupsDataData CollectionDecision AidDevelopmentEffectivenessFosteringGoalsHealthHealth systemHealthcareHealthcare SystemsIndividualInterventionIntervention TrialInterviewKnowledgeLearningLife StyleManualsMental DepressionOutcomePainPain interferencePain managementPatientsPharmaceutical PreparationsPhasePrimary Health CareProceduresProtocols documentationProviderRandomizedRandomized Controlled TrialsReach Effectiveness Adoption Implementation and MaintenanceResearchResourcesSamplingStructureSystemTestingTimeWaiting ListsWorkarmblack patientcare providerschronic depressionchronic painchronic pain patientcomorbid depressioncomorbiditycomparison interventiondepressive symptomseffectiveness implementation studyeffectiveness studyeffectiveness testingempoweredevidence baseexperiencefollow-upfuture implementationheuristicsimplementation barriersimplementation facilitationimprovedindividual patientintervention deliverymultilevel analysismultimodalitynovelnovel strategiespain catastrophizingpain outcomepatient engagementpatient-clinician communicationpatient-level barrierspilot testpreferenceprimary outcomeracial disparityrecruitsafety netsecondary outcomesocioeconomic disadvantagetreatment adherencetreatment comparisontreatment guidelines
项目摘要
Project Summary
Nonpharmacological pain treatments (NPTs) are supported by evidence and widely recommended in treatment
guidelines. However, these approaches remain underused. Even as access increases, several patient-related
barriers remain, including lack of knowledge about NPT availability and effectiveness, poor patient-provider
communication, and challenges to engagement and adherence –particularly important as NPTs typically
require more commitment, time, and effort than taking medications. These barriers may be especially
pronounced for patients with comorbid depression, since depressive symptoms can interfere with pain
management, and for Black patients, who continue to experience disparities in pain treatment, including being
offered fewer treatment options than White patients. The overall goal of this proposal is to refine, test, and
prepare to implement a novel approach to overcoming patient-related barriers to NPT use that is tailored to
Black patients with comorbid pain and depression. EQUIPD (Equity Using Interventions for Pain and
Depression) uses 1) a decision aid focused on NPTs to increase use, and 2) a coach to foster patient
engagement and treatment adherence. Drawing on a heuristic model of multi-level mechanisms of racial
injustice in pain outcomes, EQUIPD begins by focusing on the individual, while laying the groundwork for later
intervention at the structural level (i.e., clinic/healthcare system) through subsequent system-wide
implementation. In Phase 1, we will establish a patient engagement panel, elicit primary care providers’
perspectives on the decision aid, and conduct a 2-arm pilot randomized controlled trial (RCT) of the
intervention to test and refine procedures. In Phase 2 we will conduct a fully powered (N=250) RCT and
evaluate facilitators and barriers to system-wide implementation. The primary outcome of EQUIPD is pain
interference (at 6 months); secondary outcomes include depression, NPT use, anxiety, pain catastrophizing,
and patient engagement. To facilitate implementation planning, we will conduct interviews with a purposefully
sampled subset of intervention patients and with clinicians, administrators, and other clinic staff to optimize the
intervention and elucidate critical factors for system-wide implementation. EQUIPD simultaneously addresses
disparities pervasive in pain treatment and challenges related to comorbid pain and depression, by partnering
with and empowering minoritized patients to find safe, effective approaches to chronic pain that best match
their values, preferences, and lifestyles. Moreover, EQUIPD helps to advance the National Pain Strategy by
promoting multi-modal approaches to pain care that is tailored to individual patients’ needs.
项目摘要
非药物疼痛治疗(NPT)得到证据支持并在治疗中被广泛推荐
指南然而,这些方法仍然没有得到充分利用。即使随着访问的增加,一些与患者有关的
障碍依然存在,包括缺乏对《不扩散核武器条约》可用性和有效性的了解,
沟通,以及参与和遵守方面的挑战-特别重要,因为NPT通常
需要更多的承诺,时间和努力,而不是服用药物。这些障碍可能特别
对于患有抑郁症的患者来说,这一点很明显,因为抑郁症状会干扰疼痛
管理,以及黑人患者,他们继续经历疼痛治疗的差异,包括
提供的治疗选择比白色患者少。本提案的总体目标是完善、测试和
准备实施一种新的方法,以克服与患者有关的使用NPT的障碍,
患有疼痛和抑郁症的黑人患者。公平使用疼痛干预措施,
抑郁症)使用1)侧重于NPT的决策辅助工具来增加使用,以及2)教练来培养患者
参与和治疗依从性。借鉴种族歧视多层次机制的启发式模型,
在痛苦的结果不公正,BHD开始关注个人,同时奠定基础,
结构层面的干预(即,诊所/医疗保健系统),随后在全系统范围内
实施.在第一阶段,我们将建立一个患者参与小组,
对决策辅助的观点,并进行了一项2臂试点随机对照试验(RCT),
干预以测试和完善程序。在第2阶段,我们将进行一项全把握度(N=250)RCT,
评价全系统执行工作的促进因素和障碍。主要结局是疼痛
干预(6个月时);次要结局包括抑郁、NPT使用、焦虑、疼痛灾难化,
和患者参与。为方便实施计划,我们会有目的地与
干预患者的抽样子集,并与临床医生,管理员和其他诊所工作人员,以优化
并阐明全系统执行的关键因素。同时,
疼痛治疗中普遍存在的差异以及与共病疼痛和抑郁症相关的挑战,
与少数群体患者合作,并使他们能够找到安全、有效的慢性疼痛治疗方法,
他们的价值观、偏好和生活方式。此外,通过以下方式,
促进多模式的疼痛护理方法,适合个别患者的需要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianne Matthias其他文献
Marianne Matthias的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianne Matthias', 18)}}的其他基金
COVID-19 Impact on Pain management: Highlighting, Explaining, and Realigning services (CIPHER)
COVID-19 对疼痛管理的影响:突出显示、解释和重新调整服务 (CIPHER)
- 批准号:
10673419 - 财政年份:2022
- 资助金额:
$ 155.76万 - 项目类别:
COVID-19 Impact on Pain management: Highlighting, Explaining, and Realigning services (CIPHER)
COVID-19 对疼痛管理的影响:突出显示、解释和重新调整服务 (CIPHER)
- 批准号:
10595645 - 财政年份:2022
- 资助金额:
$ 155.76万 - 项目类别:
COVID-19 Impact on Pain management: Highlighting, Explaining, and Realigning services (CIPHER)
COVID-19 对疼痛管理的影响:突出显示、解释和重新调整服务 (CIPHER)
- 批准号:
10412749 - 财政年份:2022
- 资助金额:
$ 155.76万 - 项目类别:
Options for Pain Management using Nonpharmacological Strategies (OPTIONS)
使用非药物策略的疼痛管理选项(选项)
- 批准号:
10534972 - 财政年份:2022
- 资助金额:
$ 155.76万 - 项目类别:
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE)
疼痛中的沟通和激活,以增强关系并公平地治疗疼痛(合作)
- 批准号:
9502687 - 财政年份:2018
- 资助金额:
$ 155.76万 - 项目类别:
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE)
疼痛中的沟通和激活,以加强关系并公平地治疗疼痛(合作)
- 批准号:
10159110 - 财政年份:2018
- 资助金额:
$ 155.76万 - 项目类别:
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE)
疼痛中的沟通和激活,以加强关系并公平地治疗疼痛(合作)
- 批准号:
10213832 - 财政年份:2018
- 资助金额:
$ 155.76万 - 项目类别:
Communication and Activation in Pain to Enhance Relationships and Treat Pain with Equity (COOPERATE)
疼痛中的沟通和激活,以加强关系并公平地治疗疼痛(合作)
- 批准号:
9927912 - 财政年份:2018
- 资助金额:
$ 155.76万 - 项目类别:
Evaluation of peer Coach-Led Intervention to improve Pain Symptoms (ECLIPSE)
对同伴教练主导的改善疼痛症状干预的评估 (ECLIPSE)
- 批准号:
9145524 - 财政年份:2015
- 资助金额:
$ 155.76万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 155.76万 - 项目类别:
Fellowship Programs